Welcome to our dedicated page for Amn Healthcare SEC filings (Ticker: AMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AMN Healthcare Services filings document operating results, governance matters, capital-structure disclosures, and material events for a healthcare workforce solutions company. Form 8-K reports include quarterly and annual financial results, Regulation FD investor presentation materials, board and officer matters, and amendments to corporate bylaws.
The company's proxy materials cover annual meeting voting, board composition, shareholder proposal procedures, director nomination mechanics, governance practices, performance discussion, and capital allocation priorities. Filings also disclose segment activity across Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions, along with debt, leverage, liquidity, and risk-related reporting.
AMN Healthcare Services Inc executive Brian M. Scott, the company's CFO/COO, reported the vesting of restricted stock units into 12,212 shares of common stock on December 15, 2025. These shares were acquired at $0 per share as the units converted.
On the same date, 4,370 shares were disposed of at $16.37 per share to cover tax obligations, leaving Scott with 7,842 common shares held directly. He also holds 24,797 restricted stock units granted on December 15, 2024 under the AMN Healthcare 2017 Equity Plan, which vest on the first, second and third anniversaries of the grant date, with each unit representing one share of AMN common stock and no expiration date.
AMN Healthcare Services, Inc. reported that its Board of Directors approved amended and restated by-laws, effective immediately on December 11, 2025. The changes are designed to align its governance rules with current Delaware law and to tighten and clarify procedures around how stockholders call special meetings and bring business before meetings.
The updated by-laws refine the information and disclosure that stockholders must provide when nominating directors or submitting proposals, and they clarify the authority of the Board and the meeting chair to manage conduct at stockholder meetings. They also require director candidates to be available for interviews with Board members about their qualifications, while making additional ministerial and conforming updates.
AMN Healthcare Services (AMN) received a Schedule 13G from investors affiliated with Millennium. Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each reported beneficial ownership of 2,446,024 shares of common stock, representing 6.4% of the class, with shared voting and dispositive power over those shares and no sole power. Integrated Core Strategies (US) LLC reported beneficial ownership of 2,425,686 shares, representing 6.3% of the class, also with shared voting and dispositive power and no sole power.
The filers certified the securities were not acquired and are not held for the purpose of changing or influencing control of AMN. The filing relates to AMN’s common stock, par value $0.01 per share, and lists a Date of Event of 11/04/2025.
AMN Healthcare Services (AMN) filed its Q3 2025 report, showing revenue of $634.5 million, down from $687.5 million a year ago. Net income rose to $29.3 million from $7.0 million, with diluted EPS of $0.76 versus $0.18.
Year to date, revenue was $1,982.2 million versus $2,249.1 million, and the company reported a net loss of $88.0 million, primarily reflecting a non-cash goodwill impairment of $109.5 million and a $18.3 million long‑lived asset impairment recorded earlier in the year. Q3 included a $39.2 million gain on the sale of the Smart Square scheduling software, for which AMN received $65.3 million in cash and a $10.0 million 9.000% promissory note due January 1, 2027.
Operating cash flow reached $193.9 million for the nine months. Cash and cash equivalents were $52.6 million, and total stockholders’ equity was $644.4 million at September 30, 2025. Segment Q3 revenue: Nurse & Allied $361.5 million, Physician & Leadership $178.2 million, Technology & Workforce $94.8 million.
Subsequent events: On October 6, 2025, AMN issued $400.0 million of 6.500% senior notes due 2031 and amended its credit facility (maturity extended to October 6, 2030; revolving commitments set at $450.0 million; leverage covenant updated). On October 22, 2025, it redeemed the $500.0 million 2027 notes using note proceeds, revolver borrowings, and operating cash.
AMN Healthcare Services, Inc. furnished an update on its business by reporting results for the fiscal quarter ended September 30, 2025. The company provided the details in a press release attached as Exhibit 99.1.
The information related to these quarterly results is furnished under Item 2.02 and, as stated, is not deemed “filed” under Section 18 of the Exchange Act. AMN’s common stock trades on the NYSE under the symbol AMN.
AMN Healthcare Services (AMN): Schedule 13G/A filed by FMR LLC
FMR LLC and Abigail P. Johnson filed Amendment No. 1 to their Schedule 13G for AMN Healthcare Services. The filing reports beneficial ownership of 4,409.09 shares of common stock, representing 0.0% of the class as of 09/30/2025. FMR reports 2,154.00 shares with sole voting power and 4,409.09 shares with sole dispositive power, with 0 shared voting or dispositive power.
The filing indicates ownership of five percent or less of the class. It also states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control. One or more other persons may have the right to receive dividends or sale proceeds, with no single such interest exceeding five percent.
AMN Healthcare (AMN) insider transaction: On 10/15/2025, an officer (Chief Information and Digital) reported the vesting of 9,330 shares of common stock upon Restricted Stock Units (RSUs) settlement. The filer disposed of 3,339 shares at $20.69 to cover taxes. Following these transactions, the filer beneficially owned 38,699 shares directly. RSUs remaining after the event totaled 9,331.
The RSUs were granted on 10/15/2024 under the AMN Healthcare 2017 Equity Plan and vest in two tranches on the first and second anniversaries of the grant date, subject to credited service.
AMN Healthcare Services (AMN) reported an insider transaction by its Chief Legal Officer. On 10/15/2025, 4,976 shares of common stock were acquired upon the vesting of Restricted Stock Units (transaction code M).
On the same date, 1,212 shares were withheld for taxes at $20.69 per share (code F). Following these transactions, the officer directly beneficially owned 20,496 shares. The RSUs were granted on 10/15/2024 under the AMN Healthcare 2017 Equity Plan and vest in two annual tranches.
AMN Healthcare Services (AMN) completed a refinancing move as its subsidiary issued $400.0 million 6.500% Senior Notes due January 15, 2031, guaranteed on a senior unsecured basis by the parent and certain subsidiaries. Interest is payable semi-annually on January 15 and July 15, commencing July 15, 2026. The notes are callable at 103.250% in 2027, 101.625% in 2028, and 100% thereafter; before October 15, 2027, up to 40% may be redeemed with equity proceeds at 106.500%, or otherwise at par plus a make‑whole premium. A change of control triggers a 101% repurchase offer.
The company also amended its revolving credit facility to $450.0 million (from $750.0 million) and extended maturity to October 6, 2030, while updating leverage covenants (max 5.25x through March 31, 2027; 5.00x through June 30, 2028; 4.75x thereafter) and adding a pricing tier at Net Leverage ≥4.25x. AMN expects to draw about $100.0 million on the revolver and, together with note proceeds and cash, redeem all $500.0 million 2027 notes on October 22, 2025.
AMN Healthcare Services, Inc. reports that its subsidiary AMN Healthcare, Inc. plans an unregistered offering of $400 million aggregate principal amount of senior unsecured notes due 2031 and has announced the pricing of these 2031 Notes. The company also states that the issuer has delivered a Conditional Notice of Redemption for all $500 million aggregate principal amount of its outstanding senior unsecured notes due 2027, with redemption scheduled for October 22, 2025, subject to the successful completion of the 2031 Notes offering.
AMN Healthcare Services, Inc. reports that its subsidiary AMN Healthcare, Inc. plans an unregistered offering of $400 million aggregate principal amount of senior unsecured notes due 2031 and has announced the pricing of these 2031 Notes. The company also states that the issuer has delivered a Conditional Notice of Redemption for all $500 million aggregate principal amount of its outstanding senior unsecured notes due 2027, with redemption scheduled for October 22, 2025, subject to the successful completion of the 2031 Notes offering.
AMN Healthcare Services, Inc. reports that its subsidiary AMN Healthcare, Inc. plans an unregistered offering of $400 million aggregate principal amount of senior unsecured notes due 2031 and has announced the pricing of these 2031 Notes. The company also states that the issuer has delivered a Conditional Notice of Redemption for all $500 million aggregate principal amount of its outstanding senior unsecured notes due 2027, with redemption scheduled for October 22, 2025, subject to the successful completion of the 2031 Notes offering.
AMN Healthcare Services, Inc. reports that its subsidiary AMN Healthcare, Inc. plans an unregistered offering of $400 million aggregate principal amount of senior unsecured notes due 2031 and has announced the pricing of these 2031 Notes. The company also states that the issuer has delivered a Conditional Notice of Redemption for all $500 million aggregate principal amount of its outstanding senior unsecured notes due 2027, with redemption scheduled for October 22, 2025, subject to the successful completion of the 2031 Notes offering.